Scalper1 News
The European Union’s medical advisory committee endorsed several key drugs from leading stocks Friday, making EU approval likely for some potential blockbusters: The Committee for Medicinal Products for Human Use, known by its French abbreviation, CHMP, adopted a positive opinion on Gilead Sciences ‘ (GILD) Genvoya to manage HIV infection. Genvoya is a four-drug combo pill identical to Gilead’s popular treatment Stribild, except that in place of Scalper1 News
Scalper1 News